Cathie Wood from ARK Investment Management believes US stock markets are the polar opposite of what they were in the ’90s when investors were chasing their dreams.

She gave the example of a research hospital in the UK that basic edited the genome of a 12-year-old girl suffering from leukaemia. “She had failed dozens of therapies and was out of options. Seven months later she is cancer free. Not many investors know about it,” Wood tweeted.

Also read: How to invest in startups

The ARK founder referred to a message report from the BBC, who said Alyssa, who was diagnosed with T-cell acute lymphoblastic leukemia, was cleared of her cancer with the help of grassroots editing by doctors at Great Ormond Street Hospital.

Wood stressed that the 2022 financial market defeat has drowned out the news and that few analysts are trying to fully appreciate the potential.

“Last year’s bear market stifled this news, although it caused a stir at ASH American Society of Hematology Conference. While a cure doesn’t make a trend, few analysts rule out any possibility that gene editing could cure cancer,” she said.

Stocks: That ARK Genomic Revolution ETF ARKG holds shares like Beam Therapeutics Inc BEAM, Verve Therapeutics Inc VERV and Crispr Therapeutics AG CRSP who work in the field of gene editing.

“In our view, US stock markets today are 180 degrees different from where they were in the tech and telecom bubble of the late 1990s. Unlike then, the technologies are ready and the costs low enough for prime time. Back then, investors were chasing the dream. Now they’re running away,” Wood said.

Tesla CEO expressed his admiration for Wood’s observations and responded with a single word – “Wow”.

Continue reading: ‘Big Short’ Investor Michael Burry Says Salesforce Stock Should Have Fallen: ‘Downsizing Isn’t a Reason to Own This’